Network Meta-analysis of the Benefit of Aspirin with Rivaroxaban vs. Clopidogrel for Patients with Stable Symptomatic Lower Extremity Arterial Disease

  • Graeme K Ambler
  • Joakim Nordanstig
  • Christian-Alexander Behrendt
  • Christopher P Twine

Related Research units

Bibliographical data

Original languageEnglish
ISSN1078-5884
DOIs
Publication statusPublished - 01.10.2021
PubMed 34452837